Venoruton®: Post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton® a five-year, open-registry, efficacy study

Panminerva Medica

Volumn 53, Issue 3 SUPPLEMENT, 2011, Pages 13-19

  Ippolito, E ^a,b   Belcaro, G ^a,b   Dugall, M ^a,b   Cesarone, M R ^a,b   Feragalli, B ^a,b   Errichi, B M ^a,b   Gizzi, G ^a,b   Pellegrini, L ^a,b   Ledda, A ^a,b   Luzzi, R ^a,b   Ricci, A ^a,b   Bavera, P ^a,b   Hosoi, M ^a,b   Corsi, M ^a,b   Errichi, S ^a,b  

^a UNIVERSITY OF CHIETI   (Italy)

^b International Vein Center and Academy   (Italy)

Author keywords

Compression bandages; Edema.; Varicose ulcer; Veins

Indexed keywords

DRUG DERIVATIVE; MONOXERUTIN; TROXERUTIN;

ADULT; ANKLE; ARTICLE; COMPRESSION GARMENT; EDEMA; FEMALE; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; POSTTHROMBOSIS SYNDROME; RECURRENT DISEASE; REGISTER; TREATMENT OUTCOME; VEIN INSUFFICIENCY;

ADULT; ANKLE; COMBINED MODALITY THERAPY; EDEMA; FEMALE; HUMANS; HYDROXYETHYLRUTOSIDE; MALE; MIDDLE AGED; POSTTHROMBOTIC SYNDROME; RECURRENCE; REGISTRIES; STOCKINGS, COMPRESSION; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 84859471493     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Beckers C, Zijilstra JA. New aspects of the pathogenesis of CVI and the site of action of VenorutonR. Phlebology Digest 2001; 14; 8-11.
2. 2 measurements, leg volumetry and ambulatory venous pressure measurements. Phlebology 1989; 4; 23-6.
3. Cesarone MR, Ricci A, Belcaro G, Pomante P, Candiani C, Leon M et al. Acute effect of hydroxyethylrutosides on capillary filtration in normal volunteers, patients with venous hypertension and in patients with diabetic microangiopathy (a dose-comparison study). Vasa 1992; 21: 76-9.
4. Belcaro G, Errichi BM. Evaluation of capillary permeability in patients with venous hypertension treated with Venoruton by the vacuum suction chamber (VSC) device. Phlebologie 1988; 41: 847-9.
5. Incandela L, Belcaro G, Renton S, De Sanctis MT, Cesarone MR, Bavera P et al. HR(Paroven,Venoruton;0(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: A prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Therap 2002; 7( Suppl. I); S7-10.
6. Incandela L, Cesarone MR, Belcaro G, Dugall M, Acerbi G. Treatment of diabetic microangiopathy and edema with HR(Paroven,Venoruton; 0(beta-hydroxyethyl)-rutosides): A prospective, placebo-controlled, randomized study. J Cardiovasc Pharmacol Therap 2002; 7( Suppl. I); S11-3.
7. Cesarone MR, Belcaro G, Geroulakos G, Griffin M, Lennox A, De Sanctis MT et al. Flight microangiopathy in medium-to-long-distance flights: Prevention of edema and microcirculation alterations with HR(Paroven,Venoruton; 0(beta-hydroxyethyl)-rutosides). J Cardiovasc Pharmacol Therap 2002; 7( Suppl. I); S17-9.
8. Cesarone MR, Incandela L, De Sanctis MT, Belcaro G, Griffin M, Ippolito E. Treatment of edema and increased capillary filtration in venous hypertension with HR(Paroven,Venoruton; 0(beta-hydroxyethyl)-rutosides): A clinical, prospective, placebo-controlled, randomized, dose-ranging trial. J Cardiovasc Pharmacol Therap 2002; 7( Suppl. 1); S21-5.
9. Cesarone MR, Incandela L, De Sanctis MT, Belcaro G, Dugall M, Acerbi G. Variations in plasma free-radicals in patients with venous hypertension with HR(Paroven,Venoruton; 0(beta-hydroxyethyl)rutosides): a clinical, prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Therap 2002;7(Suppl. I);S25-8. (Pubitemid 34408832)
10. Belcaro G, Nicolaides AN, Stansby G. London: The Venous Clinic, Imperial College Press; 1999.
11. De Sanctis MT, Cesarone MR, Incandela L, Belcaro G, Acerbi G. Methods of evaluation and quantification of microangiopathy in high perfusion microangiopathy (Chronic venous insufficiency and diabetic microangiopathy). J Cardiovasc Pharmacol 2002; 7( Suppl. I); S3-5.
12. Belcaro G, Nicolaides AN. Noninvasive investigations in vascular disease. London: Imperial College Press; 2001.
13. Almond NE et al. A laser doppler blood flowmeter used to detect thermal entrainment in normal persons and patients with Raynaud's phenomenon. In: Spence VA, Sheldon CD. editors. Practical aspects of skin blood flow measurement. London: Biological Engineering Society; 1985.
14. Anning ST. The cause and treatment of leg ulcers. Lancet 1952; 2: 789-91.
15. Anning ST. Leg ulcers. Their causes and treatment. London: J & A Churchill Ltd.; 1954.
16. Anning ST. The historical aspect. In: Dodd H, Cockett FB, editors. The pathology and surgery of the veins of the lower limb. Edinburgh: Churchill-Livingstone; 1976.
17. Belcaro G. The role of transcutaneous PCO2 measurements in association with laser Doppler flowmetry in venous hypertension. Phlebology 1988; 3: 189-93.
18. Belcaro G, Grigg M, Rulo A, Nicolaides AN. Blood flow in the perimalleolar skin in relation to posture in patients with venous hypertension. Ann Vase Surg 1989; 1: 5-8.
19. Belcaro G, Christopoulos D, Nicolaides AN. Skin flow and swelling in postphlebitic limbs. Vasa 1989; 18: 136-8.
20. Belcaro G, Nicolaides AN, Volteas N, Leon M. Skin flow, the venoarteriolar response and capillary filtration in diabetics. A 3-year study. Angiology 1992; 43: 490-4.
21. Belcaro G, Bollinger A, Hoffman U, Nicolaides AN. Laser Doppler Flowmetry. London: Med-Orion; 1994.
22. Thulesius O. Capillary filtration under normal and pathological con. ditions. Angiologia 1973; 10: 198-201.
23. Dalen JE, Hirsh J, Guyatt GH. Sixth ACCP consensus conference on antithrombotic therapy. Chest 2001; 1: 119-21.
24. Nicolaides AN. Prevention Of venous thromboembolism. International Consensus Statement. London: Med-Orion; 2002.
25. Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL et al; American venous forum international Ad Hoc committee for revision of the CEAP classification. Revision of the CEAP classification for chronic venous disorders: Consensus statement. J Vasv Surg 2004; 40: 1248-52.
26. Stuard S, Cesarone MR, Belcaro G, Dugall M, Ledda A, Cacchio M et al. Five-year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using o-/beta-hydroxyethyl)- rutosides: A prospecticve, comparative clinical registry. Int J Angiol 2008; 17: 143-8.
27. Belcaro G, Cesarone MR, Ledda A, Cacchio M, Ruffini I, Ricci A et al. Five-year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)- rutosides: a prospective comparative clinical registry. Angiology 2008;59(Suppl. 1):14S-20S. (Pubitemid 351253078)
28. Grossi MG, Belcaro G, Cesarone MR. Iontophoresis, a model of venous hypertension and microangiopathy with histamine injection. Data on file
29. Grossi MG, Belcaro G, Cesarone MR. Iontophoresis, a model of venous hypertension and microangiopathy with reactive hyperemia. Data on file
30. Poynard T, Valterio C. Meta-analysis of hydroxyethylrutosides in the treatment of chronic venous insufficiency. Vasa 1994; 23: 244-60.
31. Ekestrom S, Welti R. The affinity of hydroxyethyl-rutosides for the venous wall and its efficacy in preventing early occlusion of aortocoronary vein bypass grafts. Phlebology 1990; 5( Suppl l); 41-8.
32. Yang X, Wang F, Hu S. The electrochemical oxidation of troxerutin and its sensitive determination in pharmaceutical dosage forms at PVP modified carbon paste electrode. Colloids Surf B Biointerfaces 2006;52:8-13. (Pubitemid 44301871)
33. Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A et al. Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: Improvement with Venoruton. J Cardiovasc Pharmacol Ther 2006; 11: 93-8.
34. Gutierrez RM, Solis RV, Baez EG, Martinez FM. Effect on capillary permeability in rabbits of iridoids from Buddleia scordioides. Phytother Res 2006;20:542-5. (Pubitemid 44065134)
35. Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci A et al. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology 2006;57:131-8. (Pubitemid 44438564)
36. Furfaro AL, Menini S, Patriarca S, Pesce C, Odetti P, Cottalasso D et al. HNE-dependent molecular damage in diabetic nephropathy and its possible prevention by N-acetyl-cysteine and oxerutin. Biofactors 2005;24:291-8. (Pubitemid 41750553)
37. Maurya DK, Balakrishnan S, Salvi VP, Nair CK. Protection of cellular DNA from gamma-radiation-induced damages and enhancement in DNA repair by troxerutin. MoI Cell Biochem 2005;280:57-68. (Pubitemid 41829800)
38. Chung HK, Choi SM, Ahn BO, Kwak HH, Kim JH, Kim WB. Efficacy of troxerutin on streptozotocin-induced rat model in the early stage of diabetic retinopathy. Arzneimittelforschung 2005;55:573-80. (Pubitemid 41546102)
39. Cesarone MR, Belcaro G, Pellegrini L, Ledda A, Vinciguerra G, Ricci et al. HR, • 0-(beta-hydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology 2005;56:165-72. (Pubitemid 40404471)
40. Adam BS, Pentz R, Siegers CP, Strubelt O, Tegtmeier M. Troxerutin protects the isolated perfused rat liver from a possible lipid peroxidation by coumarin. Phytomedicine 2005;12:52-61. (Pubitemid 40174329)
41. Cesarone MR, Incandela L, DeSanctis MT, Belcaro G, Griffin M, Ippolito E. Treatment of edema and increased capillary filtration in venous hypertension with HR (Paroven, Venoruton; 0-(betahydroxyethyl)-rutosides): a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. J Cardiovasc Pharmacol Ther 2002;7(Suppl l):S21-4. (Pubitemid 34408831)
42. Belcaro G, Cesarone MR. Trombosi venosa ed embolia polmonare. Turin: Minerva Medica; 2011.
43. Cesarone MR, Belcaro G, Ippolito E, Pellegrini L, Ledda A, Luzzi R et al. Clinical improvement in venous insufficiency (CVI) (signs and symptoms) with VENORUTON. AN 8-month, open-registry, cost-efficacy study. Panminerva Med 2010; 52( 2 Suppl l): 43-8.
44. Christopoulos D, Tachtsi M, Pitoulias G, Belcaro G, Papadimitriou D. Hemodynamic follow-up of iliofemoral venous thrombosis. Int Angiol 2009; 28: 394-9.
45. Kakkos SK, Rivera MA, Matsagas MI, Lazarides MK, Robless P, Belcaro G et al. Validation of the new venous severity scoring system in varicose vein surgery. J Vase Surg 2003;38:224-8. (Pubitemid 41123245)